lamivudine has been researched along with Growth Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acosta, S; Balogun, K; Guzman Lenis, MS; Mount, HT; Sarkar, A; Serghides, L | 1 |
| Arici, ZS; Berberoğlu, M; Demirçeken, F; Girgin, N; Kansu, A; Kuloğlu, Z; Ocal, G | 1 |
1 trial(s) available for lamivudine and Growth Disorders
| Article | Year |
|---|---|
The influence of interferon-alpha and combination interferon-alpha and lamivudine therapy on height and weight in children with chronic hepatitis B infection.
Topics: Antiviral Agents; Body Height; Body Weight; Child; Child, Preschool; Drug Therapy, Combination; Female; Growth Disorders; Hepatitis B, Chronic; Humans; Interferon-alpha; Lamivudine; Male | 2007 |
1 other study(ies) available for lamivudine and Growth Disorders
| Article | Year |
|---|---|
In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice.
Topics: Animals; Anti-HIV Agents; Atazanavir Sulfate; Developmental Disabilities; Dideoxynucleosides; Emtricitabine; Exploratory Behavior; Female; Fetal Growth Retardation; Growth Disorders; Hand Strength; HIV Protease Inhibitors; Homing Behavior; Lamivudine; Male; Mice; Mice, Inbred C57BL; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Reflex, Abnormal; Reflex, Righting; Sensation Disorders; Taxis Response; Tenofovir | 2020 |